News
The fourth beaten-down stock with an apparent price dislocation that I bought during Wall Street's historic volatility is ...
BioMarin (BMRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BioMarin (BMRN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
2d
Zacks Investment Research on MSNWill Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely OnThe American trade structure is witnessing a transformative shift, thanks to the Trump administration’s sweeping new tariff ...
Mark Cosentino, D.P.M., Ph.D., has joined City of Hope®, one of the largest and most advanced cancer research and treatment ...
Viridian Therapeutics, Inc. (NASDAQ: VRDN) has announced the appointment of Jeff Ajer to its board of directors. Ajer, who ...
4d
Zacks Investment Research on MSN3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great ...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results